FSD Pharma Inc - Ordinary Shares - Class B (Sub Voting)
HUGE
Get informed when a big investor buys or sells
+ FollowMarket Cap$66.67K
Close$
$0.04
50.5% downside
Current Fair Value
50.5% downsideOvervalued by 50.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $66,671.00 |
|---|---|
| Enterprise Value | $-2,614,774.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.85 |
| Outstanding Shares | 64,116,500 |
Return
| Return on Equity | -71.50% |
|---|---|
| Return on Assets | -51.39% |
| Return on Invested Capital | -107.41% |
Valuation & Multiples
| P/E Ratio | -0.15 |
|---|---|
| PEG | 0.24 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.24 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.24 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About FSD Pharma Inc
9 employees
CEO: Raza Bokhari Innovet Italia is an innovative animal health company, founded in Italy in 1996. Its main goal is to bring scientific innovation in niche fields of the veterinary market. The philosophy that drives Innovet's development is to follow wher...